to live healthier lives!
Invar portfolio comprises 6 European quality brands. These include a line of nonhormonal products to treat common skin disorders Skin-cap, a serum for fighting nail fungus Mycosan and a new molecule for treatment of herpes simplex labialis Erazaban, as well as a vaginal antiseptic Fluomizin®, a combination drug for restoration of normal vaginal flora Gynoflor® E and a line for intimate hygiene Epigen Intim.
At year-end 2014, Invar ranked among TOP-50 pharmaceutical companies by its sales. The company outpaced the market by 33%, with its evolution index (i.e., change in share of market volume) being one of the highest in the rating. Over the past four years, the company's sales have increased from 700 million rubles up to 3 billion rubles.